Analysts expect Keros Therapeutics to post earnings of ($1.36) per share and revenue of $37.32 million for the quarter. Keros Therapeutics Price Performance NASDAQ KROS opened at $10.56 on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback